Skip to main content

Table 3 Hematological parameters before and after initial PRRT

From: Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival

  Baseline (mean ± SD) n= After 4 Cycles Difference (%) p-value (paired t-test)
WBC (103/μl) 6.59 ± 2.12 35 4.48 ± 1.29 − 32.0 < 0.001
Erythrocytes (106/μl) 4.48 ± 0.63 35 4.11 ± 0.54 −8.3 < 0.001
HB (g/dl) 13.43 ± 2.81 35 13.17 ± 1.40 − 1.9 = 0.506
PLT count (103/μl) 254.86 ± 110.57 35 167.71 ± 50.62 −34.2 < 0.001